CN
Pdevelopment
Home  /  Pdevelopment  / 
  • Project
  • Indication
  • Drug Discovery
  • Clinical candidate compounds
  • IND
  • Phase Ia Clinical
  • Phase Ib Clinical
  • Phase Ⅱ Clinical
KF-0210
  • CRC,LC,GC,BC,SCCE
  • Osteoarthritis (OA)
KBP-2205
  • Solid Tumor
KBP-2506
  • Allergies, dermatitis
Two undisclosed
  • Oncology, Autoimmune
0512-63020039
info@keytherapharma.com
Unit B2-508, Bio-Bay, 218 Xinghu Street, SIP, Suzhou, Jiangsu, China
Copyright © 2022 Keythera (Suzhou) Biopharmaceuticals Co., Ltd. All rights reserved Filing number:苏ICP备2020059848号-1 苏公网安备32059002005508号

Scan and follow us